Page last updated: 2024-10-19

nitrous oxide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

nitrous oxide has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, K1
Aosaki, T1
Furukawa, Y1
Ohta, M1
Kano, Y1
Tsuboyama, A1
Sakamoto, S1
Miura, Y1
Sakuraya, K1
Fuke, N1

Other Studies

1 other study available for nitrous oxide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Antileukemic effect of nitrous oxide in a patient with chronic myelogenous leukemia.
    American journal of hematology, 1989, Volume: 30, Issue:2

    Topics: Adult; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Nitrous Oxide

1989